China Medical System Gained Exclusive Commercialization Right of Class 1 Innovative Drug Targeting Gout and Hyperuricemia China Medical System Holdings Ltd. Dec 02, 2024 21:30 HKT/SGT Read More
Everest Medicines Announces Acceptance of VELSIPITY New Drug Application in Hong Kong Everest Medicines Limited Dec 02, 2024 10:34 HKT/SGT Read More
Hua Medicine Announces Successful U.S. Phase I Results on Its 2nd Generation GKA Candidate Hua Medicine Nov 30, 2024 21:08 HKT/SGT Read More
Hua Medicine Announces Successful H.K. SENSITIZE Study Results at the CBIIC Hua Medicine Nov 30, 2024 20:34 HKT/SGT Read More
LEQEMBI (Lecanemab) for the Treatment of Alzheimer's Disease Launched in South Korea Eisai Nov 28, 2024 15:26 HKT/SGT Read More
Kingworld-Longde Life and Health Industrial Park Grand Opening Kingworld Medicines Group Nov 27, 2024 14:48 HKT/SGT Read More
Eisai Signs Research Collaboration Agreement with The National Center of Neurology and Psychiatry to Initiate Apolipoprotein E Genetic Testing in the "AD-DMT Registry" in Japan Eisai Nov 26, 2024 14:50 HKT/SGT Read More
雅各臣公佈二零二五財年中期業績 持續經營業務溢利飈升44.2% Jacobson Pharma Corporation Limited Nov 22, 2024 10:00 HKT/SGT Read More
Jacobson Pharma Announces FY2025 Interim Results Jacobson Pharma Corporation Limited Nov 22, 2024 10:00 HKT/SGT Read More
Rozebalamin for Injection 25mg (Mecobalamin) for Amyotrophic Lateral Sclerosis Launched in Japan Eisai Nov 20, 2024 10:51 HKT/SGT Read More
Anticancer Agent "TASFYGO Tablets 35mg" (Tasurgratinib Succinate) Launches in Japan for Biliary Tract Cancer with FGFR2 Gene Fusion or Rearrangements Eisai Nov 20, 2024 09:24 HKT/SGT Read More